Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X.
Source: Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Abstract
BACKGROUND:
IL-6 is a proinflammatory cytokine which is involved in the maintenance of the humoral response in various autoimmune disorders. Cerebrospinal fluid (CSF) IL-6 has shown to be increased in neuromyelitis optica (NMO). The soluble form of IL-6 receptor (sIL-6R), which links to IL-6, can activate biological responses in cells. Whether or not sIL-6R is altered in NMO has not been clarified.
OBJECTIVE:
To measure CSF IL-6 and sIL-6R in NMO and multiple sclerosis (MS) patients, and investigate whether IL-6 and sIL-6R have possible uses as sensitive biomarkers for diseases activity.
METHODS:
CSF concentrations of IL-6 and sIL-6R were measured by an ELISA in NMO (n = 22) and MS (n = 18) patients, as well as control subjects (n = 14).
RESULTS:
The concentration of IL-6 levels were higher in NMO compared to MS (p = 0.032) and the controls (p = 0.023). The levels of sIL-6R were also higher in NMO compared to MS (p = 0.002) and the controls (p < 0.001). CSF sIL-6R was associated with an Expanded Disability Status Scale score in NMO (p = 0.005) but not in MS (p = 0.891). In the MS subgroup, sIL-6R concentrations were associated with CSF white blood cells (p = 0.034).
CONCLUSIONS:
Our study revealed that CSF sIL-6R was increased in NMO patients, and correlated with clinical presentations.
Copyright © 2012 S. Karger AG, Basel.
Neuroimmunomodulation. 2012;19(5):304-8. doi: 10.1159/000339302. Epub 2012 Jul 6.
PMID: 22777162 [PubMed – indexed for MEDLINE]